These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7698665)

  • 21. PCR-based construction of long hammerhead ribozymes.
    Zillmann M; Robinson G
    Methods Mol Biol; 1997; 74():131-9. PubMed ID: 9204428
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of loop size in antisense and target RNAs on the efficiency of antisense RNA control.
    Hjalt T; Wagner EG
    Nucleic Acids Res; 1992 Dec; 20(24):6723-32. PubMed ID: 1282705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
    Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
    Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the efficiency of antisense and EGS methods.
    Salavati R; Altman S
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):63-5. PubMed ID: 9512097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved high-level expression system for eukaryotic genes in Escherichia coli using T7 RNA polymerase and rare ArgtRNAs.
    Schenk PM; Baumann S; Mattes R; Steinbiss HH
    Biotechniques; 1995 Aug; 19(2):196-8, 200. PubMed ID: 8527135
    [No Abstract]   [Full Text] [Related]  

  • 28. Intracellular expression and function of antisense catalytic RNAs.
    Castanotto D; Scherr M; Rossi JJ
    Methods Enzymol; 2000; 313():401-20. PubMed ID: 10595369
    [No Abstract]   [Full Text] [Related]  

  • 29. Design and production of asymmetric hammerhead ribozymes.
    Tabler M; Sczakiel G
    Methods Mol Biol; 1997; 74():141-9. PubMed ID: 9204429
    [No Abstract]   [Full Text] [Related]  

  • 30. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
    Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
    Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The T7 concatemer junction sequence interferes with expression from a downstream T7 promoter in vivo.
    Harvey B; Korus M; Goldman E
    Gene Expr; 1999; 8(3):141-9. PubMed ID: 10634316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A stable hammerhead structure is not required for endonucleolytic activity of a ribozyme in vivo.
    Steinecke P; Steger G; Schreier PH
    Gene; 1994 Nov; 149(1):47-54. PubMed ID: 7958987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of two types of termination signal for bacteriophage T7 RNA polymerase.
    Macdonald LE; Durbin RK; Dunn JJ; McAllister WT
    J Mol Biol; 1994 Apr; 238(2):145-58. PubMed ID: 8158645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terminators of transcription with RNA polymerase from Escherichia coli: what they look like and how to find them.
    Brendel V; Hamm GH; Trifonov EN
    J Biomol Struct Dyn; 1986 Feb; 3(4):705-23. PubMed ID: 3078109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual interactions between cleavage products of a cis-cleaving hammerhead ribozyme.
    Castanotto D; Chow WA; Li H; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):499-506. PubMed ID: 9918114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro cleavage of HPV16 E6 and E7 RNA fragments by synthetic ribozymes and transcribed ribozymes from RNA-trimming plasmids.
    He YK; Lu CD; Qi GR
    FEBS Lett; 1993 May; 322(1):21-4. PubMed ID: 8387026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3'-End modification of the adenoviral VA1 gene affects its expression in human cells: consequences for the design of chimeric VA1 RNA ribozymes.
    Barcellini-Couget S; Fenard D; Bertrand E; Singer RH; Lefebvre JC; Doglio A
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):379-90. PubMed ID: 9826265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.